Identification of Early Cardiovascular Disease Risk Factors in Normal-weight Obesity
Completed · Not applicable
Conditions studied: Metabolic Syndrome, Obesity
In brief
The purpose of this study is to identify early cardiovascular disease risk factors in those with "normal-weight obesity" (i.e., normal body, but high body fat percentage) that better track with their long-term cardiovascular disease risk.
Key facts
- Study ID
- NCT05008952
- Run by
- Oklahoma State University
- People needed
- 30
- Starts
- 2020-09-01
- Expected to finish
- 2021-07-20
- Last updated by the study team
- 2021-08-17
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Control group: normal BMI, body fat percentage < 25% for men and 35% for women
- Normal-weight obesity group: normal BMI, body fat percentage > 25% for men and 35% for women
- Metabolic syndrome group: BMI > 30 and 2 or more of the following: blood pressure >130/85 mmHg, fasting glucose >100 mg/dL, fasting triglycerides >150 mg/dL, HDL cholesterol < 40 mg/dL (men) or < 50 mg/dL (women).
You may not qualify if…
- Presence of pacemaker
- Pregnant
- use of tobacco products
- using lipid lowering drugs
Where it is running
- Oklahoma State University — Stillwater, Oklahoma, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.